Literature DB >> 1583050

Arthroplasty of the first metatarsophalangeal joint with a double-stem silicone implant. Results in patients who have degenerative joint disease failure of previous operations, or rheumatoid arthritis.

A Cracchiolo1, J B Weltmer, G Lian, T Dalseth, F Dorey.   

Abstract

Sixty-six patients who had a total of eighty-six double-stem silicone implants in the first metatarsophalangeal joint were followed prospectively for an average of 5.8 years (range, two to fifteen years). There were two groups of patients: thirty-four patients (thirty-seven implants) who had degenerative joint disease (including those who had hallux rigidus or in whom a previous operation on a bunion had failed) and thirty-two patients (forty-nine implants) who had rheumatoid arthritis. The implants were used only if the patient was a candidate for an excisional arthroplasty or an arthrodesis; they were not used in patients who wished to maintain or adopt very active use of the foot (such as in running, jogging, and tennis) or to wear very high heels. Twenty-eight (82 per cent) of the thirty-four patients in the first group were completely satisfied and three (9 per cent) were somewhat satisfied. However, three patients (9 per cent), all of whom had had a failed bunionectomy, were dissatisfied; the ages of these three patients were less than the average age of all patients in the first group. Radiographs showed a fracture in three implants, but the patients had a good clinical result and an additional operation was not warranted. Twenty-seven (84 per cent) of the thirty-two patients in the second group were completely satisfied, four (13 per cent) were somewhat satisfied, and one (3 per cent) was dissatisfied. Radiographs showed a fracture in five implants. Four of the implants caused no symptoms, and the result was good; the fifth one was fragmented and was removed because of symptoms. Radiographs showed radiolucent areas around the implant and hypertrophic changes in many patients. There was no evidence of synovitis, such as that caused by silicone, either clinically or radiographically. We found that the double-stem silicone implant was effective in reconstructing the first metatarsophalangeal joint but emphasize our belief that it should be used only in carefully selected patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583050

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  8 in total

Review 1.  [Endoprosthetic replacement of hallux rigidus].

Authors:  H-P Kundert; H Zollinger-Kies
Journal:  Orthopade       Date:  2005-08       Impact factor: 1.087

Review 2.  [Results for endoprosthetic care in patients younger than 50 years].

Authors:  J Ziegler; M Amlang; M Bottesi; S Kirschner; W-C Witzleb; K-P Günther
Journal:  Orthopade       Date:  2007-04       Impact factor: 1.087

3.  Arthrodesis in the treatment of hallux rigidus.

Authors:  V Ettl; S Radke; M Gaertner; M Walther
Journal:  Int Orthop       Date:  2003-08-26       Impact factor: 3.075

4.  The rheumatoid forefoot.

Authors:  Francis Brooks; Kartik Hariharan
Journal:  Curr Rev Musculoskelet Med       Date:  2013-12

5.  Hállux Rígidus: prospective study of joint replacement with hemiarthroplasty.

Authors:  Alexandre Leme Godoy Dos Santos; Fernando Aires Duarte; Carlos Augusto Itiu Seito; Rafael Trevisan Ortiz; Marcos Hideyo Sakaki; Túlio Diniz Fernandes
Journal:  Acta Ortop Bras       Date:  2013-03       Impact factor: 0.513

Review 6.  Hallux rigidus.

Authors:  Bryant Ho; Judith Baumhauer
Journal:  EFORT Open Rev       Date:  2017-03-13

7.  Failed Hydrogel Synthetic Cartilage Implant With Osteolytic Cyst Formation in the First Metatarsophalangeal Joint.

Authors:  Jason Fogleman; Abrianna Robles; Johnathan Hollyfield; Scott Whitlow; Gregory A Lundeen
Journal:  Foot Ankle Orthop       Date:  2020-07-31

Review 8.  May footwear be a predisposing factor for the development of hallux rigidus? A review of recent findings.

Authors:  Gabriele Colò; Federico Fusini; Kristijan Zoccola; Alessandro Rava; Elena Manuela Samaila; Bruno Magnan
Journal:  Acta Biomed       Date:  2021-07-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.